Shattuck Labs, Inc.
News
HC Wainwright Reiterates Buy Rating for Shattuck Labs (NASDAQ:STTK)
Ticker Report HC Wainwright reissued their buy rating on shares of Shattuck Labs (NASDAQ:STTK - Free Report) in a report published on Tuesday, Benzinga reports. The firm currently has a $16.00 price target on the...\n more…
Shattuck Labs Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Benzinga Across the recent three months, 7 analysts have shared their insights on Shattuck Labs STTK, expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.\n more…
Shattuck Labs's SL-172154: A Novel CD47 Therapy Overcoming Previous Challenges with Promising Clinical Prospects
TipRanks Financial Blog In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Shattuck Labs (STTK - Research Report), with a price t...\n more…
Shattuck Labs (NASDAQ:STTK) Price Target Cut to $8.00 by Analysts at Citigroup
Ticker Report Shattuck Labs (NASDAQ:STTK - Free Report) had its price objective reduced by Citigroup from $9.00 to $8.00 in a research report sent to investors on Thursday, Benzinga reports. Citigroup currently...\n more…
Shattuck Labs, Inc.'s (NASDAQ:STTK) institutional investors lost 24% last week but have benefitted from longer-term gains
Simply Wall St Key Insights Given the large stake in the stock by institutions, Shattuck Labs' stock price might be vulnerable to...\n more…